Sentinel Lymph Node Biopsy in Early Breast Cancer Using Patent Blue Dye as a Single Identification Method: Experience of an Academic Center
Gomaa, A., Hussin, M., Gomaa, A. (2024). Sentinel Lymph Node Biopsy in Early Breast Cancer Using Patent Blue Dye as a Single Identification Method: Experience of an Academic Center. EKB Journal Management System, 30(5), 1531-1541. doi: 10.21608/zumj.2024.269494.3167
Ahmed Gomaa; Mahmoud Gamal Moustafa Hussin; Ayman Mohamed Mahmoud Gomaa. "Sentinel Lymph Node Biopsy in Early Breast Cancer Using Patent Blue Dye as a Single Identification Method: Experience of an Academic Center". EKB Journal Management System, 30, 5, 2024, 1531-1541. doi: 10.21608/zumj.2024.269494.3167
Gomaa, A., Hussin, M., Gomaa, A. (2024). 'Sentinel Lymph Node Biopsy in Early Breast Cancer Using Patent Blue Dye as a Single Identification Method: Experience of an Academic Center', EKB Journal Management System, 30(5), pp. 1531-1541. doi: 10.21608/zumj.2024.269494.3167
Gomaa, A., Hussin, M., Gomaa, A. Sentinel Lymph Node Biopsy in Early Breast Cancer Using Patent Blue Dye as a Single Identification Method: Experience of an Academic Center. EKB Journal Management System, 2024; 30(5): 1531-1541. doi: 10.21608/zumj.2024.269494.3167

Sentinel Lymph Node Biopsy in Early Breast Cancer Using Patent Blue Dye as a Single Identification Method: Experience of an Academic Center

Zagazig University Medical Journal
Volume 30, Issue 5, August 2024, Page 1531-1541  XML PDF (1.06 MB)
Document Type: Original Article
DOI: 10.21608/zumj.2024.269494.3167
View on SCiNiTO View on SCiNiTO
Authors
Ahmed Gomaa email 1; Mahmoud Gamal Moustafa Hussin2; Ayman Mohamed Mahmoud Gomaa3
1Surgical Oncology, Faculty of Medicine, Suez Canal University
2Surgical Oncology, Faculty of Medicine Suez Canal University
3Surgical Oncology Faculty of Medicine Suez Canal University
Abstract
Introduction Sentinel lymph node biopsy (SLNB) has become the standard of care in the assessment of metastatic spread to axillary lymph nodes in cases with early breast cancer. The use of single or dual method for identification of the sentinel nodes was an area of much research that concluded that dual method using both dye and radiolabeled tracer has a preference given higher identification rates. Methods In this study we assessed our experience with SLNB using patent blue dye in the period 2019-2023 in patients with early breast cancer eligible for SLNB treated in Suez Canal University Hospitals. The primary outcome was to estimate the identification rate and percentage of upstaging and need for axillary dissection (AD) following SLNB. Results A total of 128 patients were included and successful identification of SLN was attained in 122 patients (95.3%). 95 of them showed negative nodes while metastatic deposits was identified in 27 patients ( 22.1%) that necessitated completion axillary clearance in 16 ( 13.1%). Conclusion SLNB is a reliable method even in the setting allowing only single method of identification giving patients with early breast cancer the chance to avoid unnecessary axillary clearance and its future morbidity.
Keywords
Sentinel lymph node biopsy; Breast cancer; Dye method; Identification rate; Axillary nodes
Statistics
Article View: 106
PDF Download: 57